Autolus Therapeutics PLC Sponsored ADR (AUTL) Moves 35.5% Higher: Will This Strength Last?Zacks Investment Research • 05/13/21
Autolus Therapeutics to Present New Data on AUTO1 in r/r Indolent B Cell Lymphomas at the European Hematology Association Virtual CongressGlobeNewsWire • 05/12/21
Autolus Therapeutics Plc (AUTL) CEO Christian Itin on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/10/21
Autolus Therapeutics Reports First Quarter 2021 Financial Results and Operational ProgressGlobeNewsWire • 05/06/21
Autolus Therapeutics Receives Innovation Passport and entry into ILAP for AUTO4 for the treatment of T cell receptor constant region beta chain 1 (TRBC1) positive T cell lymphomasGlobeNewsWire • 04/20/21
Autolus Therapeutics announces appointment of Martin Murphy as Non-executive ChairmanGlobeNewsWire • 04/19/21
Autolus Therapeutics Receives PRIME designation for AUTO1 for the treatment of adult ALLGlobeNewsWire • 04/01/21
Autolus Therapeutics' (AUTL) CEO Christian Itin on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/04/21
Autolus Therapeutics PLC Sponsored ADR (AUTL) Surges 6.5%: Is This an Indication of Further Gains?Zacks Investment Research • 03/02/21
Autolus Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional ADSsGlobeNewsWire • 02/12/21
Autolus Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on March 4GlobeNewsWire • 02/04/21
Autolus Therapeutics PLC Sponsored ADR (AUTL) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 01/27/21
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the 62nd ASH Annual MeetingGlobeNewsWire • 12/07/20
Autolus Therapeutics presents compelling AUTO1 data from ALLCAR Phase 1 study in Adult Acute Lymphoblastic Leukemia (ALL) during the 62nd ASH Annual MeetingGlobeNewsWire • 12/05/20
Autolus: Short To Medium-Term Clinical Catalysts May Drive Stock Price UpsideSeeking Alpha • 11/19/20
Autolus Therapeutics to host Investor Conference Call to discuss AUTO1 and AUTO3 data presented at ASH and to participate in the Jefferies Virtual London Healthcare ConferenceGlobeNewsWire • 11/17/20
Autolus Therapeutics PLC (AUTL) CEO Christian Itin on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/08/20